These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36517390)

  • 1. Evaluation of Safety Measures at a Medical Summer Camp During the SARS-CoV-2 Pandemic.
    Wilkinson K; Ata A; Neaton S; Woll C
    Wilderness Environ Med; 2023 Mar; 34(1):77-81. PubMed ID: 36517390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicomponent Strategies to Prevent SARS-CoV-2 Transmission - Nine Overnight Youth Summer Camps, United States, June-August 2021.
    Van Naarden Braun K; Drexler M; Rozenfeld RA; Deener-Agus E; Greenstein R; Agus M; Joffe M; Kasowitz A; Levy P; Nerwen C
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(40):1420-1424. PubMed ID: 34618796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing and Mitigating SARS-CoV-2 Transmission - Four Overnight Camps, Maine, June-August 2020.
    Blaisdell LL; Cohn W; Pavell JR; Rubin DS; Vergales JE
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1216-1220. PubMed ID: 32881850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exclusion of SARS-COV-2 From Two Maine Overnight Camps July-August 2020.
    Kowalsky RH; Fine S; Eisenberg MA
    Disaster Med Public Health Prep; 2022 Oct; 16(5):1792-1794. PubMed ID: 33762061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing and Nonpharmaceutical Interventions for Prevention of SARS-CoV-2 in 20 US Overnight Camps in Summer 2021.
    Blaisdell L; Rising J; van Zyl A; Finn J; Vergales J
    Public Health Rep; 2022; 137(5):1007-1012. PubMed ID: 35856437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigation measures against Coronavirus Disease 2019 (COVID-19) in overnight faith-based camps: summer 2021.
    Kalu IC; Wagner BE; Armstrong SC; Permar S; Coffman S; Freeman C; D'Agostino EM
    Public Health; 2024 Jul; 232():82-85. PubMed ID: 38749152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
    Constantin AM; Noertjojo K; Sommer I; Pizarro AB; Persad E; Durao S; Nussbaumer-Streit B; McElvenny DM; Rhodes S; Martin C; Sampson O; Jørgensen KJ; Bruschettini M
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD015112. PubMed ID: 38597249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-pharmaceutical interventions and COVID-19 cases in US summer camps: results from an American Camp Association survey.
    Suh HH; Meehan J; Blaisdell L; Browne L
    J Epidemiol Community Health; 2022 Apr; 76(4):327-334. PubMed ID: 34750230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England.
    Ismail SA; Saliba V; Lopez Bernal J; Ramsay ME; Ladhani SN
    Lancet Infect Dis; 2021 Mar; 21(3):344-353. PubMed ID: 33306981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid return to normal activities at a residential summer camp during the COVID-19 pandemic.
    Klunk A; Holloway R; Babaoff A; Jelin EB
    Z Gesundh Wiss; 2022; 30(11):2657-2663. PubMed ID: 34493964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
    Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
    Pizarro AB; Persad E; Durao S; Nussbaumer-Streit B; Engela-Volker JS; McElvenny D; Rhodes S; Stocking K; Fletcher T; Martin C; Noertjojo K; Sampson O; Verbeek JH; Jørgensen KJ; Bruschettini M
    Cochrane Database Syst Rev; 2022 May; 5(5):CD015112. PubMed ID: 35514111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.